ERBB2 and breast carcinoma: In breast cancer for instance, HER2 expression between initial tumor tissues and corresponding CTCs are contradictory, with a concordance of around 90% for some of them 52,53, inconsistency for others 54 or fluctuating variations in the course of the disease 55.